New Poll Finds Older Americans Believe Medicare Should Cover Weight-Loss Drugs

Follow Drugslib on

Medically reviewed by Drugs.com.

By Physician’s Briefing Staff HealthDay Reporter

WEDNESDAY, Dec. 13, 2023 -- According to the latest University of Michigan National Poll on Healthy Aging, about three in four older Americans (76 percent) believe Medicare should cover the cost of weight-loss medications like Ozempic, Wegovy, or Zepbound.

More than four out of five older adults (83 percent) think insurance companies should pay for drugs that help people with obesity manage their weight, according to poll results from more than 2,600 people ages 50 to 80 years.

A 2003 law currently prohibits Medicare from covering medications specifically for weight loss, although the federal insurance program can cover drugs that help people with type 2 diabetes manage their weight, researchers said in background notes.

In the poll, researchers found wide interest among older adults for using weight-loss drugs to drop extra pounds. About one in four poll respondents said they are overweight, and 63 percent of them are interested in taking a weight-loss medication. So are 45 percent of those who have diabetes, regardless of their weight. The drugs appear to make a good impression as well. Among those who had ever taken a weight-loss medication, 83 percent said they would do so again.

Poll results show that Ozempic/Wegovy has largely driven this new interest in weight-loss medications. The poll revealed that 61 percent of older adults had heard of the diabetes drug Ozempic, but only 18 percent had heard of the version approved specifically for weight loss, Wegovy. Other weight-loss drugs were much less familiar to poll respondents. Only 13 percent had heard of an older drug called phentermine, and just 3 percent had heard of Qsymia, Saxenda, or Contrave.

More Information

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2023-12-14 08:15

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords